To those on the AR Medicaid DUR Board “Interested Party List”:
The Arkansas Medicaid DUR Board agenda for the October
16, 2019 meeting will be available on the AR Medicaid website.
For those drug companies that have a drug listed on the agenda
and wish to submit a request to make public comments on your drug, the deadline
to submit the request with the required data is
by close of business. The documentation provided will be forwarded to our Board
members prior to the meeting. Please provide the following per the current DUR
- The speaker’s name, title, relevant credentials, and organization;
- Contact information for the speaker including address, telephone number, and email;
- The agenda item(s) which the speaker intends to address;
- Prepared comments; and
- An electronic copy of any presentation materials the speaker intends to use.
Please do not submit a copy of the drug’s package insert in lieu
of the public comments as we already have copies of all of the drug package
inserts. As a reminder, the total comment time is 6 minutes per drug.
If there is more than one speaker for the same drug, the speakers must split
the 6 minute total comment time and
the public comments applies to every speaker for the drug.
A copy of the proposed criteria for the specific agenda item on which an individual requests
to speak may be requested from the Chairperson three (3) weeks prior to
the DUR Board meeting. The information will be in draft form and may be
changed by the DUR Board prior to being finalized. As such, the draft
criteria should be shared with clinicians or patients.
Interested parties for products or topics listed on the quarterly meeting agenda may reach
out to the Arkansas Medicaid Pharmacy Program after the agenda is posted to
request a meeting with staff prior to the DUR Board meeting. These
meetings may be held in-person or by conference call up to three (3) weeks
prior to the DUR meeting and shall be no longer than in
duration. These meetings will be disclosed to the DUR Board, along with any
written materials provided in the meetings, as part of the information provided
to members two (2) weeks prior to the quarterly meeting.
****NOTE THAT THE LOCATION HAS RETURNED TO THE MAGELLAN HEALTH BOARDROOM FOR THIS MEETING.****
Drive, Suite 1120
Little Rock, AR